• Cell Lysis Buffer for WB and IP: Assay Logic

  2026-08-17

  Cell lysis buffer for WB and IP can do more than release proteins: it can preserve the molecular state needed to test CAF-driven chemoresistance. This guide presents a compartment-first workflow linking prostate cancer mechanism, inhibitor selection, Western blot, and immunoprecipitation sample preparation.

• Carbapenemase Gene Transfer in Enterobacter cloacae

  2026-08-16

  Chen et al. characterize carbapenemase-encoding genes in 54 carbapenem-resistant Enterobacter cloacae isolates from eight teaching hospitals in Guangdong, identifying frequent plasmid carriage and highly efficient horizontal transfer, particularly for blaNDM-1. The study combines gene localization, antimicrobial susceptibility testing, conjugation assays, mobile-element analysis, and strain typing to connect resistance mechanisms with transmission potential.

• DFCP1 Controls Starvation-Driven ATGL Lipolysis

  2026-08-15

  The reference study identifies DFCP1/ZFYVE1 as a nutrient-sensitive regulator of lipid droplet catabolism that recruits and retains ATGL on lipid droplets during starvation. Its central innovation is to connect DFCP1-dependent spatial organization of ATGL with reduced lipolytic turnover, distinguishing this mechanism from broader effects on lipophagy or lipid droplet biogenesis.

• SIRT4, Glutamine Metabolism, and Liver Fibrosis

  2026-08-14

  The reference study identifies SIRT4-mediated control of glutamate dehydrogenase as a metabolic mechanism that restrains hepatic stellate cell activation and liver fibrosis. Its combined pharmacological and genetic evidence positions glutamine catabolism as a tractable research target while clarifying how mitochondrial metabolism contributes to fibrogenesis.

• GPR30, ER Stress, and CD4+ T Cells After Hemorrhage

  2026-08-14

  The reference study shows that estradiol restores splenic CD4+ T-cell proliferation and cytokine production after hemorrhagic shock by suppressing endoplasmic reticulum stress through ERα and GPR30, but not ERβ. Its pharmacological design links estrogen-receptor subtype activity to a defined stress pathway and provides a useful framework for studying immune dysfunction after trauma.

• 4-MUG and the Next Wave of Gaucher Translation

  2026-08-13

  How 4-MUG turns lysosomal enzyme activity into a decision-grade bridge between GCase biology, mRNA engineering, and Gaucher disease translation.

• SOD Activity Assay Kit | K2035

  2026-08-13

  The Superoxide Dismutase Activity Assay Kit (K2035) provides a colorimetric method for measuring SOD activity in biological fluids through WST-1 reduction at 450 nm. It is intended for research on oxidative stress and antioxidative enzyme function, not for diagnostic, clinical, or medical use.

• Cycloheximide: A Causal Lens on Translation

  2026-08-12

  Cycloheximide is more than a protein biosynthesis inhibitor: it is a controlled perturbation for separating translational elongation from initiation, protein turnover, and apoptosis. This guide connects rigorous assay design with recent insight into HuR-regulated viral IRES translation.

• WZ4003 Lowers Tau Ser356 in Alzheimer’s Models

  2026-08-12

  Taylor et al. associate tau phosphorylation at Ser356 with Alzheimer’s disease pathology and test whether pharmacological NUAK1/2 inhibition can reduce this species in ex vivo brain tissue. WZ4003 lowered p-tau Ser356 in adult human brain slice cultures, while mouse slices showed broader, culture-phase-dependent effects that highlight both translational promise and important safety limitations.

• PARP7–STAT1/2 Control of EAE and Interferon Signaling

  2026-08-11

  Xu et al. identify PARP7 as a post-translational checkpoint that weakens type I interferon signaling by ADP-ribosylating STAT1 and STAT2, promoting their ubiquitination and p62-mediated autophagic degradation. Inhibition of PARP7 restored STAT1/2-dependent signaling and alleviated experimental autoimmune encephalomyelitis in mice, providing a mechanistic framework for multiple sclerosis research while leaving important questions about human translation.

• Bobcat339 for TET-Directed Methylation Studies

  2026-08-11

  Bobcat339 is a cytosine structure-based TET enzyme inhibitor for dissecting DNA methylation regulation and gene transcription modulation. This article presents a causal assay framework linking TET activity with UHRF1, super-enhancers, TGM2, and osteogenic dysfunction.

• Ziprasidone HCl: Bench Workflows and Use Cases

  2026-08-10

  Ziprasidone HCl supports two distinct research directions: receptor-focused neuroscience experiments and GOT1-centered tumor metabolism assays. This practical guide translates product specifications and reference-study insights into controlled cell, enzyme, permeability, and translational workflows.

• GKT137831 Workflow for Nox1/Nox4 Oxidative Stress Studies

  2026-08-09

  Build reproducible oxidative-stress assays with GKT137831, a dual NADPH oxidase Nox1/Nox4 inhibitor suited to vascular, fibrotic, and metabolic disease models. A membrane-focused ferroptosis framework adds a practical way to distinguish upstream ROS control from terminal plasma-membrane injury.

• Carbenoxolone disodium: Practical Protocol Guide

  2026-08-08

  Carbenoxolone disodium is a research tool for probing 11β-hydroxysteroid dehydrogenase activity, glucocorticoid access, and gap junction communication in cell- and tissue-based workflows. It is useful for mechanistic experiments, but should not be treated as a selective probe for in vivo efficacy studies or assays requiring strict off-target control.

• Methylprednisolone Sodium Succinate: Assay Logic

  2026-08-07

  Methylprednisolone Sodium Succinate is a synthetic corticosteroid whose value depends on matching molecular, cellular, and functional endpoints. This assay-centered guide explains how to interpret concentration-dependent immune effects and translate them responsibly across inflammation, tumor-cell, and injury research.

11722 records 1/782 page Next 12345 下5页 Last page